Drugs
October 2005: Additions and Deletions to the Drug Product List
24th Edition: Cumulative Supplement Number 10
[Prescription - OTC]
NOTE: The format for the Monthly Additions/Deletions Drug Product List has changed as of the July Cumulative Supplement (CS) of the 21st Edition to mirror the CS. Refer to the CS Preface section 1.5 CUMULATIVE SUPPLEMENT LEGEND.
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST
AMOXICILLIN CAPSULE; ORAL AMOXICILLIN >A> AB AUROBINDO 250MG N65271 001 Nov 09, 2005 Oct NEWA >A> AB 500MG N65271 002 Nov 09, 2005 Oct NEWA TABLET; ORAL AMOXICILLIN >A> AB AUROBINDO 500MG N65256 001 Nov 09, 2005 Oct NEWA >A> AB 875MG N65256 002 Nov 09, 2005 Oct NEWA BETAMETHASONE VALERATE CREAM; TOPICAL >D> BETADERM >D> AB ROACO EQ 0.1% BASE N18839 001 Jun 30, 1983 Oct DISC >A> @ EQ 0.1% BASE N18839 001 Jun 30, 1983 Oct DISC BETATREX >D> AB SAVAGE LABS EQ 0.1% BASE N18862 001 Aug 31, 1983 Oct DISC >A> @ EQ 0.1% BASE N18862 001 Aug 31, 1983 Oct DISC LOTION; TOPICAL BETATREX >D> AB SAVAGE LABS EQ 0.1% BASE N18867 001 Aug 31, 1983 Oct DISC >A> @ EQ 0.1% BASE N18867 001 Aug 31, 1983 Oct DISC OINTMENT; TOPICAL BETATREX >D> AB SAVAGE LABS EQ 0.1% BASE N18863 001 Aug 31, 1983 Oct DISC >A> @ EQ 0.1% BASE N18863 001 Aug 31, 1983 Oct DISC CILOSTAZOL TABLET; ORAL CILOSTAZOL >A> AB SANDOZ 50MG N77310 001 Nov 08, 2005 Oct NEWA CITALOPRAM HYDROBROMIDE TABLET; ORAL CITALOPRAM HYDROBROMIDE >A> AB PLIVA EQ 10MG BASE N77232 001 Oct 31, 2005 Oct NEWA >A> AB EQ 20MG BASE N77232 002 Oct 31, 2005 Oct NEWA >A> AB EQ 40MG BASE N77232 003 Oct 31, 2005 Oct NEWA CLOBETASOL PROPIONATE CREAM; TOPICAL TEMOVATE >A> AB1 + ALTANA 0.05% N19322 001 Dec 27, 1985 Oct CAHN >D> AB1 + GLAXOSMITHKLINE 0.05% N19322 001 Dec 27, 1985 Oct CAHN TEMOVATE E >A> AB2 + ALTANA 0.05% N20340 001 Jun 17, 1994 Oct CAHN >D> AB2 + GLAXOSMITHKLINE 0.05% N20340 001 Jun 17, 1994 Oct CAHN GEL; TOPICAL TEMOVATE >A> AB + ALTANA 0.05% N20337 001 Apr 29, 1994 Oct CAHN >D> AB + GLAXOSMITHKLINE 0.05% N20337 001 Apr 29, 1994 Oct CAHN OINTMENT; TOPICAL TEMOVATE >A> AB + ALTANA 0.05% N19323 001 Dec 27, 1985 Oct CAHN >D> AB + GLAXOSMITHKLINE 0.05% N19323 001 Dec 27, 1985 Oct CAHN SOLUTION; TOPICAL TEMOVATE >A> AT + ALTANA 0.05% N19966 001 Feb 22, 1990 Oct CAHN >D> AT + GLAXOSMITHKLINE 0.05% N19966 001 Feb 22, 1990 Oct CAHN >A> SPRAY; TOPICAL >A> CLOBEX >A> + DOW PHARM SCI 0.05% N21835 001 Oct 27, 2005 Oct NEWA CLOTRIMAZOLE TROCHE/LOZENGE; ORAL CLOTRIMAZOLE >A> AB PADDOCK 10MG N76763 001 Oct 28, 2005 Oct NEWA CYANOCOBALAMIN GEL, METERED; NASAL NASCOBAL >A> + QOL MEDCL 0.5MG/INH N19722 001 Nov 05, 1996 Oct CAHN >D> + QUESTCOR PHARMS 0.5MG/INH N19722 001 Nov 05, 1996 Oct CAHN SPRAY, METERED; NASAL NASCOBAL >A> + QOL MEDCL 0.5MG/SPRAY N21642 001 Jan 31, 2005 Oct CAHN >D> + QUESTCOR PHARMS 0.5MG/SPRAY N21642 001 Jan 31, 2005 Oct CAHN DANAZOL CAPSULE; ORAL DANAZOL >D> AB BARR 50MG N74582 003 May 29, 1998 Oct CTEC >A> 50MG N74582 003 May 29, 1998 Oct CTEC >D> AB 100MG N74582 002 May 29, 1998 Oct CTEC >A> 100MG N74582 002 May 29, 1998 Oct CTEC >D> AB 200MG N74582 001 Aug 09, 1996 Oct CRLD >A> AB + 200MG N74582 001 Aug 09, 1996 Oct CRLD >D> DANOCRINE >D> AB SANOFI 50MG N17557 003 Oct DISC >A> @ 50MG N17557 003 Oct DISC >D> AB 100MG N17557 004 Oct DISC >A> @ 100MG N17557 004 Oct DISC >D> AB + 200MG N17557 002 Oct DISC >A> @ 200MG N17557 002 Oct DISC DANTROLENE SODIUM CAPSULE; ORAL DANTROLENE SODIUM >A> AB AMIDE PHARM 25MG N76686 001 Oct 24, 2005 Oct NEWA >A> AB 50MG N76686 002 Oct 24, 2005 Oct NEWA >A> AB 100MG N76686 003 Oct 24, 2005 Oct NEWA DIAZEPAM GEL; RECTAL >D> DIASTAT >D> VALEANT 5MG/ML (5MG/ML) N20648 002 Jul 29, 1997 Oct DISC >A> @ 5MG/ML (5MG/ML) N20648 002 Jul 29, 1997 Oct DISC >D> 10MG/2ML (5MG/ML) N20648 003 Jul 29, 1997 Oct DISC >A> @ 10MG/2ML (5MG/ML) N20648 003 Jul 29, 1997 Oct DISC >D> 15MG/3ML (5MG/ML) N20648 004 Jul 29, 1997 Oct DISC >A> @ 15MG/3ML (5MG/ML) N20648 004 Jul 29, 1997 Oct DISC >D> + 20MG/4ML (5MG/ML) N20648 005 Jul 29, 1997 Oct DISC >A> @ 20MG/4ML (5MG/ML) N20648 005 Jul 29, 1997 Oct DISC DIASTAT ACUDIAL >D> VALEANT 20MG/4ML (5MG/ML) N20648 006 Sep 15, 2005 Oct CRLD >A> + 20MG/4ML (5MG/ML) N20648 006 Sep 15, 2005 Oct CRLD DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE; ORAL DIPHENHYDRAMINE HCL >D> AA MK LABS 25MG N83087 001 Oct DISC >A> @ 25MG N83087 001 Oct DISC >D> AA 50MG N83087 002 Oct DISC >A> @ 50MG N83087 002 Oct DISC DOXYCYCLINE HYCLATE TABLET; ORAL DOXYCYCLINE HYCLATE >A> AB LANNETT EQ 20MG BASE N65277 001 Nov 10, 2005 Oct NEWA EPINEPHRINE INJECTABLE; IM-SC EPINEPHRINE >D> + HOLLISTER STIER LABS EQ 0.15MG /DELIVERY N20800 002 May 28, 2004 Oct CAHN >A> + VERUS PHARMS EQ 0.15MG /DELIVERY N20800 002 May 28, 2004 Oct CAHN TWINJECT 0.30 >D> + HOLLISTER STIER LABS EQ 0.3MG /DELIVERY N20800 001 May 30, 2003 Oct CAHN >A> + VERUS PHARMS EQ 0.3MG /DELIVERY N20800 001 May 30, 2003 Oct CAHN ERYTHROMYCIN GEL; TOPICAL EMGEL >A> @ ALTANA 2% N63107 001 Aug 23, 1991 Oct CAHN >D> @ GLAXOSMITHKLINE 2% N63107 001 Aug 23, 1991 Oct CAHN ETHANOLAMINE OLEATE INJECTABLE; INJECTION ETHAMOLIN >A> + QOL MEDCL 50MG/ML N19357 001 Dec 22, 1988 Oct CAHN >D> + QUESTCOR PHARMS 50MG/ML N19357 001 Dec 22, 1988 Oct CAHN FENOFIBRATE TABLET; ORAL FENOFIBRATE >A> AB RANBAXY 54MG N76635 001 Oct 31, 2005 Oct NEWA >A> 107MG N76635 002 Oct 31, 2005 Oct NEWA >A> AB 160MG N76635 003 Oct 31, 2005 Oct NEWA FLUOXETINE HYDROCHLORIDE CAPSULE; ORAL FLUOXETINE >A> AB RXELITE EQ 10MG BASE N75464 001 Jan 30, 2002 Oct CAHN >A> AB EQ 20MG BASE N75464 002 Jan 30, 2002 Oct CAHN >D> AB SIEGFRIED EQ 10MG BASE N75464 001 Jan 30, 2002 Oct CAHN >D> AB EQ 20MG BASE N75464 002 Jan 30, 2002 Oct CAHN FLUTICASONE PROPIONATE CREAM; TOPICAL CUTIVATE >A> AB + ALTANA 0.05% N19958 001 Dec 18, 1990 Oct CAHN >D> AB + GLAXOSMITHKLINE 0.05% N19958 001 Dec 18, 1990 Oct CAHN LOTION; TOPICAL CUTIVATE >A> + ALTANA 0.05% N21152 001 Mar 31, 2005 Oct CAHN >D> + GLAXOSMITHKLINE 0.05% N21152 001 Mar 31, 2005 Oct CAHN OINTMENT; TOPICAL CUTIVATE >A> AB + ALTANA 0.005% N19957 001 Dec 14, 1990 Oct CAHN >D> AB + GLAXOSMITHKLINE 0.005% N19957 001 Dec 14, 1990 Oct CAHN FOLIC ACID TABLET; ORAL FOLIC ACID >D> AA MK LABS 1MG N83526 001 Oct DISC >A> @ 1MG N83526 001 Oct DISC >A> AA PHARM FORM 1MG N85061 001 Oct CAHN >D> AA PVT FORM 1MG N85061 001 Oct CAHN FUROSEMIDE TABLET; ORAL FUROSEMIDE >A> AB EXCELLIUM 20MG N77293 001 Nov 09, 2005 Oct NEWA >A> AB 40MG N77293 002 Nov 09, 2005 Oct NEWA >A> AB 80MG N77293 003 Nov 09, 2005 Oct NEWA GLIPIZIDE; METFORMIN HYDROCHLORIDE TABLET; ORAL >A> GLIPIZIDE AND METFORMIN HCL >A> AB COREPHARMA 2.5MG;250MG N77507 001 Oct 27, 2005 Oct NEWA >A> AB 2.5MG;500MG N77507 002 Oct 27, 2005 Oct NEWA >A> AB 5MG;500MG N77507 003 Oct 27, 2005 Oct NEWA >A> AB TEVA PHARMS 2.5MG;250MG N77270 001 Oct 28, 2005 Oct NEWA >A> AB 2.5MG;500MG N77270 002 Oct 28, 2005 Oct NEWA >A> AB 5MG;500MG N77270 003 Oct 28, 2005 Oct NEWA METAGLIP >D> BRISTOL MYERS 2.5MG;250MG N21460 001 Oct 21, 2002 Oct CFTG >A> AB 2.5MG;250MG N21460 001 Oct 21, 2002 Oct CFTG >D> 2.5MG;500MG N21460 002 Oct 21, 2002 Oct CFTG >A> AB 2.5MG;500MG N21460 002 Oct 21, 2002 Oct CFTG >D> + 5MG;500MG N21460 003 Oct 21, 2002 Oct CFTG >A> AB + 5MG;500MG N21460 003 Oct 21, 2002 Oct CFTG GRAMICIDIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE SOLUTION/DROPS; OPHTHALMIC NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN >A> AT PHARMAFORCE 0.025MG/ML;EQ 1.75MG BASE/ML;10,000 N65187 001 Oct 28, 2005 Oct NEWA HYALURONIDASE >A> INJECTABLE; INJECTION >A> AMPHADASE >A> + AMPHASTAR PHARM 150 UNITS/ML N21665 001 Oct 26, 2004 Oct CDFR >A> HYDASE >A> + PRIMAPHARM 150 UNITS/ML N21716 001 Oct 25, 2005 Oct NEWA >D> INJECTABLE; SUBCUTANEOUS >D> AMPHADASE >D> + AMPHASTAR PHARM 150 UNITS/ML N21665 001 Oct 26, 2004 Oct CDFR HYDROCHLOROTHIAZIDE TABLET; ORAL HYDROCHLOROTHIAZIDE >A> AB PHARM FORM 25MG N85181 001 Oct CAHN >A> AB 50MG N85182 001 Oct CAHN >D> AB PVT FORM 25MG N85181 001 Oct CAHN >D> AB 50MG N85182 001 Oct CAHN HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM TABLET; ORAL HYZAAR >A> MERCK 12.5MG;100MG N20387 003 Oct 20, 2005 Oct NEWA HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE SOLUTION/DROPS; OTIC NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE >A> AT PHARMAFORCE 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML N65216 001 Oct 31, 2005 Oct NEWA HYDROMORPHONE HYDROCHLORIDE TABLET; ORAL HYDROMORPHONE HCL >A> KV PHARM 2MG N77311 001 Nov 09, 2005 Oct NEWA >A> 4MG N77311 002 Nov 09, 2005 Oct NEWA >A> AB 8MG N77311 003 Nov 09, 2005 Oct NEWA IBUPROFEN TABLET; ORAL IBUPROFEN >A> AB PHARM FORM 300MG N71266 001 Oct 15, 1986 Oct CAHN >A> AB 400MG N71267 001 Oct 15, 1986 Oct CAHN >A> AB 600MG N71268 001 Oct 15, 1986 Oct CAHN >A> AB 800MG N72300 001 Jul 01, 1988 Oct CAHN >D> AB PVT FORM 300MG N71266 001 Oct 15, 1986 Oct CAHN >D> AB 400MG N71267 001 Oct 15, 1986 Oct CAHN >D> AB 600MG N71268 001 Oct 15, 1986 Oct CAHN >D> AB 800MG N72300 001 Jul 01, 1988 Oct CAHN IOTHALAMATE SODIUM, I-125 INJECTABLE; INJECTION GLOFIL-125 >A> QOL MEDCL 250-300uCi/ML N17279 001 Oct CAHN >D> QUESTCOR PHARMS 250-300uCi/ML N17279 001 Oct CAHN LOPINAVIR; RITONAVIR >A> TABLET; ORAL >A> KALETRA >A> + ABBOTT 200MG;50MG N21906 001 Oct 28, 2005 Oct NEWA METRONIDAZOLE TABLET; ORAL >D> METROMIDOL >D> AB LABS AF 250MG N74523 001 Oct 24, 1996 Oct DISC >A> @ 250MG N74523 001 Oct 24, 1996 Oct DISC >D> AB 500MG N74523 002 Oct 24, 1996 Oct DISC >A> @ 500MG N74523 002 Oct 24, 1996 Oct DISC MINOCYCLINE HYDROCHLORIDE CAPSULE; ORAL DYNACIN >A> @ MEDICIS EQ 50MG BASE N63066 001 Aug 14, 1990 Oct DISC >A> AB EQ 75MG BASE N63067 002 Sep 15, 1999 Oct CTNA >A> AB EQ 100MG BASE N63067 001 Jul 31, 1990 Oct CTNA VECTRIN >D> AB MEDICIS EQ 50MG BASE N63066 001 Aug 14, 1990 Oct DISC >D> AB EQ 75MG BASE N63067 002 Sep 15, 1999 Oct CTNA >D> AB EQ 100MG BASE N63067 001 Jul 31, 1990 Oct CTNA >A> NELARABINE >A> INJECTABLE; IV (INFUSION) >A> ARRANON >A> + GLAXOSMITHKLINE 250MG/50ML (5MG/ML) N21877 001 Oct 28, 2005 Oct NEWA NITROFURAZONE OINTMENT; TOPICAL NITROFURAZONE >D> AT TARO 0.2% N86156 001 Oct CRLD >A> + 0.2% N86156 001 Oct CRLD >D> AT WENDT 0.2% N86766 001 Oct DISC >A> @ 0.2% N86766 001 Oct DISC >D> SOLUTION; TOPICAL >D> NITROFURAZONE >D> + WENDT 0.2% N87081 001 Oct DISC >A> @ 0.2% N87081 001 Oct DISC OXICONAZOLE NITRATE CREAM; TOPICAL OXISTAT >A> + ALTANA EQ 1% BASE N19828 001 Dec 30, 1988 Oct CAHN >D> + GLAXOSMITHKLINE EQ 1% BASE N19828 001 Dec 30, 1988 Oct CAHN LOTION; TOPICAL OXISTAT >A> + ALTANA EQ 1% BASE N20209 001 Sep 30, 1992 Oct CAHN >D> + GLAXOSMITHKLINE EQ 1% BASE N20209 001 Sep 30, 1992 Oct CAHN POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE; ORAL KLOR-CON >D> AB UPSHER SMITH 8MEQ N19123 001 Apr 17, 1986 Oct CRLD >A> AB + 8MEQ N19123 001 Apr 17, 1986 Oct CRLD PREDNISONE TABLET; ORAL PREDNISONE >A> AB PHARM FORM 5MG N80209 001 Oct CAHN >D> AB PVT FORM 5MG N80209 001 Oct CAHN PROPOXYPHENE HYDROCHLORIDE CAPSULE; ORAL >D> KESSO-GESIC >D> AA MK LABS 65MG N83544 001 Oct DISC >A> @ 65MG N83544 001 Oct DISC QUETIAPINE FUMARATE TABLET; ORAL SEROQUEL >A> ASTRAZENECA EQ 50MG BASE N20639 007 Oct 04, 2005 Oct NEWA >A> EQ 400MG BASE N20639 006 Oct 04, 2005 Oct NEWA QUINIDINE SULFATE TABLET; ORAL QUINIDINE SULFATE >A> AB PHARM FORM 200MG N83808 001 Oct CAHN >D> AB PVT FORM 200MG N83808 001 Oct CAHN RAMIPRIL CAPSULE; ORAL ALTACE >D> KING PHARMS 1.25MG N19901 001 Jan 28, 1991 Oct CFTG >A> AB 1.25MG N19901 001 Jan 28, 1991 Oct CFTG >D> 2.5MG N19901 002 Jan 28, 1991 Oct CFTG >A> AB 2.5MG N19901 002 Jan 28, 1991 Oct CFTG >D> 5MG N19901 003 Jan 28, 1991 Oct CFTG >A> AB 5MG N19901 003 Jan 28, 1991 Oct CFTG >D> + 10MG N19901 004 Jan 28, 1991 Oct CFTG >A> AB + 10MG N19901 004 Jan 28, 1991 Oct CFTG >A> RAMIPRIL >A> AB COBALT 1.25MG N76549 001 Oct 24, 2005 Oct NEWA >A> AB 2.5MG N76549 002 Oct 24, 2005 Oct NEWA >A> AB 5MG N76549 003 Oct 24, 2005 Oct NEWA >A> AB 10MG N76549 004 Oct 24, 2005 Oct NEWA RIBAVIRIN CAPSULE; ORAL RIBAVIRIN >A> AB ZYDUS PHARMS USA 200MG N77224 001 Oct 28, 2005 Oct NEWA >A> SODIUM BICARBONATE >A> INJECTABLE; INJECTION >A> SODIUM BICARBONATE >A> HOSPIRA 0.9MEQ/ML N77394 001 Nov 09, 2005 Oct NEWA >A> + 1MEQ/ML N77394 002 Nov 09, 2005 Oct NEWA SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE TABLET; ORAL VISICOL >D> + INKINE 0.398GM;1.102GM N21097 001 Sep 21, 2000 Oct CAHN >A> + SALIX PHARMS 0.398GM;1.102GM N21097 001 Sep 21, 2000 Oct CAHN SOTALOL HYDROCHLORIDE TABLET; ORAL SOTALOL HCL >A> AB2 GENPHARM 80MG N77070 001 Nov 04, 2005 Oct NEWA >A> AB2 120MG N77070 002 Nov 04, 2005 Oct NEWA >A> AB2 160MG N77070 003 Nov 04, 2005 Oct NEWA >D> SULFANILAMIDE >D> CREAM; VAGINAL >D> AVC >D> @ NOVAVAX 15% N06530 003 Jan 27, 1987 Oct CAHN >A> @ PHARMELLE 15% N06530 003 Jan 27, 1987 Oct CAHN >D> SULFANILAMIDE >D> + TEVA 15% N88718 001 Sep 19, 1985 Oct DISC >A> @ 15% N88718 001 Sep 19, 1985 Oct DISC SUPPOSITORY; VAGINAL AVC >D> @ NOVAVAX 1.05GM N06530 004 Jan 27, 1987 Oct CAHN >A> @ PHARMELLE 1.05GM N06530 004 Jan 27, 1987 Oct CAHN SULFISOXAZOLE TABLET; ORAL >D> SOSOL >D> AB MK LABS 500MG N80036 001 Oct DISC >A> @ 500MG N80036 001 Oct DISC SULFISOXAZOLE >D> AB + IVAX PHARMS 500MG N80142 001 Oct CTEC >A> + 500MG N80142 001 Oct CTEC TAMOXIFEN CITRATE >A> SOLUTION; ORAL >A> SOLTAMOX >A> + SAVIENT PHARMS EQ 10MG BASE/5ML N21807 001 Oct 29, 2005 Oct NEWA TECHNETIUM TC-99M TETROFOSMIN KIT INJECTABLE; INJECTION MYOVIEW >D> GE HEALTHCARE N/A N20372 001 Feb 09, 1996 Oct CRLD >A> + N/A N20372 001 Feb 09, 1996 Oct CRLD MYOVIEW 30ML >D> GE HEALTHCARE N/A N20372 002 Jul 07, 2005 Oct CRLD >A> + N/A N20372 002 Jul 07, 2005 Oct CRLD TIMOLOL MALEATE SOLUTION/DROPS; OPHTHALMIC TIMOLOL MALEATE >D> AT FOUGERA EQ 0.25% BASE N74667 001 Mar 25, 1997 Oct DISC >A> @ EQ 0.25% BASE N74667 001 Mar 25, 1997 Oct DISC >D> AT EQ 0.5% BASE N74668 001 Mar 25, 1997 Oct DISC >A> @ EQ 0.5% BASE N74668 001 Mar 25, 1997 Oct DISC TRIAMCINOLONE ACETONIDE CREAM; TOPICAL TRIAMCINOLONE ACETONIDE >D> AT AMBIX 0.025% N87932 001 May 09, 1983 Oct DISC >A> @ 0.025% N87932 001 May 09, 1983 Oct DISC VITAMIN A PALMITATE CAPSULE; ORAL >D> VITAMIN A >D> MK LABS EQ 25,000 UNITS BASE N83457 002 Oct DISC >A> @ EQ 25,000 UNITS BASE N83457 002 Oct DISC >D> AA EQ 50,000 UNITS BASE N83457 001 Oct DISC >A> @ EQ 50,000 UNITS BASE N83457 001 Oct DISC ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE; ORAL AMBIEN CR >D> SANOFI 6.5MG N21774 002 Sep 02, 2005 Oct CPOT >A> 6.25MG N21774 002 Sep 02, 2005 Oct CPOT
ADDITIONS/DELETIONS FOR OTC DRUG PRODUCT LIST
LORATADINE >A> SUSPENSION; ORAL >A> LORATADINE >A> + TARO 1MG/ML N21734 001 Oct 04, 2005 Oct NEWA SYRUP; ORAL CLARITIN >D> + SCHERING 1MG/ML N20641 002 Nov 27, 2002 Oct CAHN >A> + SCHERING PLOUGH 1MG/ML N20641 002 Nov 27, 2002 Oct CAHN CLARITIN HIVES RELIEF >D> @ SCHERING 1MG/ML N20641 003 Nov 19, 2003 Oct CAHN >A> @ SCHERING PLOUGH 1MG/ML N20641 003 Nov 19, 2003 Oct CAHN TABLET, ORALLY DISINTEGRATING; ORAL CLARITIN HIVES RELIEF REDITAB >D> + SCHERING 10MG N20704 003 Nov 19, 2003 Oct CAHN >A> + SCHERING PLOUGH 10MG N20704 003 Nov 19, 2003 Oct CAHN CLARITIN REDITABS >D> + SCHERING 10MG N20704 002 Nov 27, 2002 Oct CAHN >A> + SCHERING PLOUGH 10MG N20704 002 Nov 27, 2002 Oct CAHN TABLET; ORAL CLARITIN >D> + SCHERING 10MG N19658 002 Nov 27, 2002 Oct CAHN >A> + SCHERING PLOUGH 10MG N19658 002 Nov 27, 2002 Oct CAHN CLARITIN HIVES RELIEF >D> + SCHERING 10MG N19658 003 Nov 19, 2003 Oct CAHN >A> + SCHERING PLOUGH 10MG N19658 003 Nov 19, 2003 Oct CAHN LORATADINE; PSEUDOEPHEDRINE SULFATE TABLET, EXTENDED RELEASE; ORAL CLARITIN-D >D> @ SCHERING 5MG;120MG N19670 002 Nov 27, 2002 Oct CAHN >A> @ SCHERING PLOUGH 5MG;120MG N19670 002 Nov 27, 2002 Oct CAHN CLARITIN-D 24 HOUR >D> + SCHERING 10MG;240MG N20470 002 Nov 27, 2002 Oct CAHN >A> + SCHERING PLOUGH 10MG;240MG N20470 002 Nov 27, 2002 Oct CAHN